ANDA 75530, held by Hikma. Milrinone Lactate.
As of Nov 16, 2026, ANDA 75530 (Milrinone Lactate), held by Hikma, was first approved by FDA on May 28, 2002, with 1 approved supplement and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 28, 2002 | Original application | Approved |
| Product | Active ingredient | Marketing |
|---|---|---|
| Milrinone LactateEQ 1MG BASE/ML ยท injectable;injection | Milrinone Lactate | Discontinued |
| Dec 10, 2007 | Supplement 1Labeling | Approved | None posted |
| May 28, 2002 | Original application | Approved |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters